1. Inicio
  2. Investigación
  3. Grupos de investigación
  4. Enfermedades Multisistémicas

Enfermedades Multisistémicas

Buscador de publicaciones

Sólo se han incluido artículos originales, editoriales y revisiones.

  • López-Rodríguez M, Torralba-Cabeza MA, de Pedro IP, Rivera A, Gil RS, Gómez-Belda A, de la Peña JLP, de Los Santos Moreno A, Selva-O'Callaghan A, Gárate IG, García AG, Hurtado R, de Ureta PT, Barba-Romero MÁ, Milisenda JC, Grau-Junyent JM.

    Screening for late-onset Pompe disease in Internal Medicine departments in Spain.

    ORPHANET JOURNAL OF RARE DISEASES . 18(1): 256-256.

    [doi:10.1186/s13023-023-02887-z]

  • de la Espriella R, Núñez-Marín G, Cobo M, de Castro Campos D, Llácer P, Manzano L, Zegrí I, Rodriguez-Pérez Á, Santas E, Lorenzo M, Miñana G, Núñez E, Górriz JL, Bayés-Genís A, Fudim M, Mullens W, Núñez J.

    Intrarenal Venous Flow Pattern Changes Do Relate With Renal Function Alterations in Acute HeartFailure.

    JACC-HEART FAILURE . 12(2): 304-318. Nº de citas: 2

    [doi:10.1016/j.jchf.2023.07.015]

  • Llàcer P, Croset F, Núñez J, Campos J, Fernández C, Fabregate M, Del Hoyo B, Ruiz R, López G, Tello S, Lorenzo A, Fernández JM, Manzano L.

    Prognostic significance of plasma chloride in elderly patients hospitalized for acute heart failure.

    ESC heart failure . 10(4): 2637-2647.

    [doi:10.1002/ehf2.14434]

  • Santiago-Vacas E, Anguita M, Casado J, García-Prieto CF, González-Costello J, Matalí A, González-Franco Á, Trueba-Sáiz Á, Manzano L.

    Current heart failure disease management and treatment in accredited units from Cardiology and Internal Medicine in Spain.

    Revista clinica espanola . 223(7): 405-413.

    [doi:10.1016/j.rceng.2023.06.004]

  • Fernández-Rodríguez JM, Casado J, Formiga F, González-Franco A, Arévalo JC, Beltrán M, Cerqueiro González JM, Llàcer P, Manzano L, Morales-Rull JL, Pérez Silvestre J, Conde-Martel A.

    Executive summary of the 2023 update on the consensus regarding basic conduct during hospital admission for patients with acute heart failure.

    Revista clinica espanola . 223(8): 499-509. Nº de citas: 2

    [doi:10.1016/j.rceng.2023.07.008]

  • Montes-Moreno S, Climent F, Fraga M, Luis Patier J, Robles-Marhuenda Á, García-Sanz R, Ocio EM, González García A, Navarro JT.

    Expert consensus on the integrated diagnosis of idiopathic multicentric Castleman disease.

    REVISTA ESPANOLA DE PATOLOGIA . 56(3): 158-167.

    [doi:10.1016/j.patol.2022.12.003]

  • Salamanca-Bautista P, Romero-Correa M, Formiga F, Antequera-Martín-Portugués I, Llàcer P, Marrero-Medina IG, Calderón-Jiménez P, Moreno-Palanco MÁ, Armengou-Arxe A, Gonzalo-Pascua S, Piñeiro-Parga P, Aramburu-Bodas Ó.

    Safety of benzodiazepines in patients with acute heart failure: A propensity score-matching study

    INTERNATIONAL JOURNAL OF CARDIOLOGY . 382: 40-45. Nº de citas: 1

    [doi:10.1016/j.ijcard.2023.04.014]

  • Montero-Pérez-Barquero M, Escobar-Cervantes C, Arévalo-Lorido JC, Conde-Martel A, Salamanca-Bautista P, Manzano-Espinosa L, Formiga F, Díez-Manglano J, Cepeda JM, González-Franco A, Casado-Cerrada J.

    Projected effectiveness of dapagliflozin in heart failure with reduced ejection fraction in clinical practice.

    Future cardiology . 19(6): 343-351.

    [doi:10.2217/fca-2023-0016]

  • Santas E, Llácer P, Palau P, De La Espriella R, Miñana G, Lorenzo M, Marín GN, Miró Ò, Chorro FJ, Genís AB, Sanchis J, Núñez J.

    Noncardiovascular morbidity and mortality across left ventricular ejection fraction categories following hospitalization for heart failure.

    Revista espanola de cardiologia (English ed.) . 77(3): 206-214. Nº de citas: 1

    [doi:10.1016/j.rec.2023.05.005]

  • Llàcer P, Núñez J, Croset F, García M, Fabregate M, Ruiz R, López G, Fernández C, Del Hoyo B, Campos J, Gomis A, Manzano L.

    Usefulness of urinary potassium to creatinine ratio to predict diuretic response in patients with acute heart failure and preserved ejection fraction.

    CLINICAL CARDIOLOGY . : .

    [doi:10.1002/clc.24040]

  • Montero-Pérez-Barquero M, Escobar-Cervantes C, Llàcer P, Quirós-López R, Trullás JC, Cerqueiro JM, Epelde-Gonzálo F, Carrera-Izquierdo M, Formiga F, González-Franco A, Casado-Cerrada J.

    Projected clinical benefits of dapagliflozin in patients with heart failure with preserved ejection fraction

    Future cardiology . 19(6): 333-342. Nº de citas: 1

    [doi:10.2217/fca-2023-0015]

  • Cobo Marcos M, de la Espriella R, Gayán Ordás J, Zegrí I, Pomares A, Llácer P, Fort A, Rodríguez Chavarri A, Méndez A, Blázquez Z, Caravaca Pérez P, Rubio Gracia J, Recio-Mayoral A, García Pinilla JM, Soler MJ, Garrido González R, Górriz JL, González Rico M, Castro A, Núñez J.

    Sex differences in Cardiorenal Syndrome: Insights from CARDIOREN Registry

    Current Heart Failure Reports . 20(3): 157-167.

    [doi:10.1007/s11897-023-00598-x]

  • Suárez Carantoña C, Escobar Cervantes C, Fabregate M, López Rodríguez M, Bara Ledesma N, Soto Pérez-Olivares J, Ruiz Ortega RA, López Castellanos G, Olavarría Delgado A, Blázquez Sánchez J, Gómez Del Olmo V, Moralejo Martín M, Pumares Álvarez MB, Sánchez Gallego MC, Llàcer P, Liaño F, Manzano L.

    Oral Sodium Chloride in the Prevention of Contrast-Associated Acute Kidney Injury in Elderly Outpatients: The PNIC-Na Randomized Non-Inferiority Trial.

    Journal Of Clinical Medicine . 12(8): .

    [doi:10.3390/jcm12082965]

  • Fanlo P, Gracia-Tello BDC, Fonseca Aizpuru E, Álvarez-Troncoso J, Gonzalez A, Prieto-González S, Freire M, Argibay AB, Pallarés L, Todolí JA, Pérez M, Buján-Rivas S, Ibáñez B.

    Efficacy and Safety of Anakinra Plus Standard of Care for Patients With Severe COVID-19: A Randomized Phase 2/3 Clinical Trial

    Jama Network Open . 6(4): . Nº de citas: 5

    [doi:10.1001/jamanetworkopen.2023.7243]

  • Ramos-Rincón JM, Ventura PS, Casas-Rojo JM, Mauri M, Bermejo CL, de Latierro AO, Rubio-Rivas M, Mérida-Rodrigo L, Pérez-Casado L, Barrientos-Guerrero M, Giner-Galvañ V, Gallego-Lezaun C, Milián AH, Manzano L, Blázquez-Encinar JC, Solís-Marquínez MN, García MG, Lobo-García J, Valente VA, Roig-Martí C, León-Téllez M, Tellería-Gómez P, González-Juárez MJ, Gómez-Huelgas R, López-Escobar A.

    Validation of the RIM Score-COVID in the Spanish SEMI-COVID-19 Registry.

    INTERNAL AND EMERGENCY MEDICINE . 18(3): 1-9.

    [doi:10.1007/s11739-023-03200-3]

  • González-Juanatey JR, Comín-Colet J, Pascual Figal D, Bayes-Genis A, Cepeda JM, García-Pinilla JM, García-Quintana A, Manzano L, Zamorano JL.

    Optimization of Patient Pathway in Heart Failure with Reduced Ejection Fraction and Worsening Heart Failure. Role of Vericiguat.

    PATIENT PREFERENCE AND ADHERENCE . 17: 839-849.

    [doi:10.2147/PPA.S400403]

  • Ruiz-Hueso R, Salamanca-Bautista P, Quesada-Simón MA, Yun S, Conde-Martel A, Morales-Rull JL, Suárez-Gil R, García-García JÁ, Llàcer P, Fonseca-Aizpuru EM, Amores-Arriaga B, Martínez-González Á, Armengou-Arxe A, Peña-Somovilla JL, López-Reboiro ML, Aramburu-Bodas Ó.

    Estimating the Prevalence of Cardiac Amyloidosis in Old Patients with Heart Failure-Barriers and Opportunities for Improvement: The PREVAMIC Study

    Journal Of Clinical Medicine . 12(6): .

    [doi:10.3390/jcm12062273]

  • Díez-Manglano J, Carretero-Gómez J, Chimeno-Viñas MM, Martín-Escalante MD, Recio-Iglesias J, Manzano-Espinosa L, Zapatero-Gaviría A, Del Prado N, Elola J.

    RECALMIN IV. Evolution in the activity of internal medicine units of the National Health System (2008-2021).

    Revista clinica espanola . 223(3): 125-133.

    [doi:10.1016/j.rceng.2023.02.001]